Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206695 · ClinicalTrials.gov registry record · NA
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
A NA study of Asthma and Pneumonia, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 3,840
- Enrollment target
- 1
- Study location
NCT05206695 is a NA study of Asthma and Pneumonia that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 3,840 participants, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (147% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05206695, a NA study of Asthma and Pneumonia, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,840 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.
Conditions Studied
Interventions
- BEHAVIORAL Multi-condition Pathway Intervention
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,840 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05206695
The ClinicalTrials.gov registry entry for NCT05206695 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,840 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (147% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Multi-condition Pathway Intervention is the first listed.
NCT05206695 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05206695 about?
NCT05206695 is a clinical study titled "Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children". This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervent...
What is the current status of trial NCT05206695?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,840 participants. The study started on 2022-05-13. Estimated completion is 2026-06-30.
What conditions does trial NCT05206695 study?
This clinical trial studies the following conditions: Asthma, Pneumonia, Bronchiolitis.
What interventions are being tested in trial NCT05206695?
The interventions under investigation include: Multi-condition Pathway Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05206695?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206695 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.